Effects of Progressive Muscle Relaxation Exercise and Finger Grip Exercise on Stress, Anxiety, Fatigue, Sleep Quality, and Physiological Parameters in Pregnant Women With Preeclampsia

The aim of this study is to examine the effects of progressive muscle relaxation exercise and finger grip exercise on stress, anxiety, sleep quality, fatigue and physiological parameters in preeclamptic pregnant women. It is thought that the study will contribute to the improvement of sleep quality by reducing the stress, anxiety and fatigue levels of pregnant women. In this study, which will examine the effects of stress, anxiety, fatigue, sleep quality and physiological parameters of preeclamptic pregnant women, progressive muscle relaxation exercise and finger grip exercise will be used in the same study. No other study has been found where these two methods were used in the same study and the specified parameters were examined together. It is thought that the results of this study will contribute to the literature. The basic questions that the study will answer are as follows: H1: The stress level of preeclamptic pregnant women in the progressive muscle relaxation exercise group is lower than that of the control group. H2: The anxiety level of preeclamptic pregnant women in the progressive muscle relaxation exercise group is lower than that of the control group. H3: The fatigue level of preeclamptic pregnant women in the progressive muscle relaxation exercise group is lower than that of the control group. H4: The sleep quality of preeclamptic pregnant women in the progressive muscle relaxation exercise group is better than that of the control group. H5: The physiological parameters of preeclamptic pregnant women in the progressive muscle relaxation exercise group are better than that of the control group. H6: The stress level of preeclamptic pregnant women in the finger grip exercise group is lower than that of the control group. H7: The anxiety level of preeclamptic pregnant women in the finger grip exercise group is lower than that of the control group. H8: The fatigue level of preeclamptic pregnant women in the finger grip exercise group is lower than that of the control group. H9: The sleep quality of preeclamptic pregnant women in the finger grip exercise group is better than the control group. H10: The physiological parameters of preeclamptic pregnant women in the finger grip exercise group are better than the control group. H11: The effects of progressive muscle relaxation exercise and finger grip exercise on stress levels are different in preeclamptic pregnant women. H12: The effects of progressive muscle relaxation exercise and finger grip exercise on anxiety levels are different in preeclamptic pregnant women. H13: The effects of progressive muscle relaxation exercise and finger grip exercise on fatigue levels are different in preeclamptic pregnant women. H14: The effects of progressive muscle relaxation exercise and finger grip exercise on sleep quality are different in preeclamptic pregnant women. H15: The physiological parameters of progressive muscle relaxation exercise and finger grip exercise are different in preeclamptic pregnant women. Researchers will divide participants into experimental and control groups to examine the effects of progressive muscle relaxation exercise and finger grip exercise on stress, anxiety, sleep quality, fatigue and physiological parameters in pregnant women with preeclampsia. There will be 3 groups in the study. Group 1: PKGE Group Group 2: Finger Grip Group Group 3: Control Group Progressive muscle relaxation exercise will be applied to group 1, finger grip exercise will be applied to group 2, and no intervention will be applied to group 3. The data of the study will be collected with the Perceived Stress Scale, State/Trait Anxiety Scale, Richard-Campbell Sleep Scale, Visual Similarity Scale for Fatigue, Physiological Parameters, VAS Score Average.

NCT Number	NCT07630623
Lead Sponsor	Hatice Nur Nefes Pala
Conditions	Pregnancy, Preeclampsia
Enrollment	90 participants
Start Date	2025-11-25
Primary Completion	2026-06-25 (estimated)
Study Completion	2026-07-25 (estimated)
Updated on ClinicalTrials.gov	2026-06-05